Association between vitamin D level and pediatric inflammatory bowel disease: A systematic review and meta-analysis

Yan-Hong Sun1, Dan-Dan Tian1, Jian-Ming Zhou1

  • 1Department of "A", Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.

Insights

This study found no direct link between vitamin D levels and pediatric inflammatory bowel disease (IBD). However, vitamin D supplementation may help reduce disease activity in children with IBD.

Area of Science:

  • Pediatric Gastroenterology
  • Nutritional Immunology
  • Inflammatory Bowel Disease Research

Background:

  • The relationship between vitamin D and pediatric inflammatory bowel disease (IBD) incidence remains unclear.
  • Previous research suggests a potential link, necessitating further investigation.

Purpose of the Study:

  • To systematically evaluate the association between vitamin D levels and pediatric IBD.
  • To determine the impact of vitamin D supplementation on disease activity in pediatric IBD patients.

Main Methods:

  • A comprehensive literature search was conducted across major scientific databases (PubMed, EMBASE, Medline, Web of Science, Google Scholar) up to January 2023.
  • Data from sixteen relevant studies were extracted and analyzed using meta-analysis techniques.

Main Results:

  • No significant difference in average vitamin D levels was observed between pediatric IBD patients and healthy controls.
  • Vitamin D supplementation was associated with a significant reduction in C-reactive protein (CRP) levels (SMD = 2.65).
  • Patients with IBD in remission showed a trend towards improvement after vitamin D supplementation (OR = 0.72).

Conclusions:

  • Current evidence does not support a direct relationship between vitamin D levels and the incidence of pediatric IBD.
  • Vitamin D supplementation appears to be beneficial in improving disease activity and reducing inflammatory markers in pediatric IBD.
  • Further prospective studies are required to definitively establish the role of vitamin D in pediatric IBD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
369
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
318
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
233
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
160
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
495
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.3K